DETTE FINNER DU PÅ INNEKLIMA.COM :
OM INNEMILJØ OG INNEKLIMA
EGEN BOLIG
SKOLER OG BARNEHAGER
YRKESBYGG
SYKDOM OG HELSEEFFEKTER
LUFTFORURENSNINGER
MÅLINGER OG ANALYSER
TILTAK
KONTAKT FOR INNEMILJØSPØRSMÅL
REGLER OG FORSKRIFTER
ØKONOMI
OM INNEKLIMA.COM

Endotoksin- og Mykotoksinlitteratur

P> "Skår 1-4" angir hvilken vitenskapelig kvalitet vedkommende publikasjon har etter Kjell Aas's vurdering. Slik skår er ikke gitt for Aas's egne publikasjoner.
skår 1 = meget god/god
skår 2 = god (akseptabel)
Skår 3 = dårlig (ikke god nok dokumentasjon)
skår 4 = meget dårlig, svak dokumentasjon

  • Braun-Fahrländer C et al (2002): Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 347:869-77 (Skår 1-(2))
  • Cadieux JE et al (1983): Spontaneous release of lipopolysaccharide by Pseudomonas aeruginosa.
    J Bacteriology; 155:817-25) (skår 1).
  • Douwes J et al (1996): Measurement of beta-(1-3)-glucans in ocupational and home environments with an inhibition enzyme immunoassay. Appl. Environ. Microbiol 62: 3176-82 (skår 1).
  • DiLuzio NR (1985): Update on the immunomodulatingt activities of glucan. Springer Semin Immunopath; 8:387-400 (skår 1-2)
  • Fogelmark B, Sjöstrand M, Williams D, Rylander R (1997): Inhalation toxicity of (1->3)-beta-D-glucan, recent advances. Mediators infl 6: 263-6. (skår 1).
  • Gereda JE, et al (2002):Relation between house-dust endotoxin exposure, type 1 T-cell development, and allergen sensitisation in infants at high risk of asthma. The Lancet 355:(number 9216).(Skår 1)
  • Hasday J D, Bascom R, Costa J J et al (1999): Bacterial endotoxin is an active component of cigarette smoke. Chest 115: 829-835. (Skår 1)
  • Hendry K M, Cole E C (1993): A review of mycotoxins in indoor air. J Toxicol Environ Health 38: 183-198.
  • Hoekstra et al (1996): Release of outer membrane fragments from Escherichia coli. Biochem Biophys Acta; 455:889-99 (skåe 1-2).
  • Holla AD, Roy SR, Liu AH 2002)Endotoxin, atopy and asthmaCurrent Opinion in Allergy and Clinical Immunology 2:141-5 Oversikt, 36 referanser(Skår 2):
  • Michel O, Kips J, Duchateau J et al (1996):Severity of asthma is related to endotoxin in house dust.Am J Respir Crit Care Med 154:1641 - 46 (skår 1-2).
  • Michel O, Nagy AN, Schroeven M et al (1997):Dose-response relationships to inhaled endotoxin in normal subjects.AM J Respir Critical Care Med: 156: 1157-64 (skår 1-2).
  • Michel O (2000): Systemic and local airways inflammatory response to endotoxin.(skår 1-2)
  • Mizoguchi K et al (1986): Augmentation of antibody responses of mice to inhaled protein antigens by simultaneously inhaled bacterial polysaccharide. Immunobiology 34: 355-65 (Skår 1).
  • Rylander O, Bake B, Fisher JJ, Helander IM (1989):Pulmonary function and symptoms after inhalation of endotoxin. Amer. Rev Respir Dis. 140:981-86 (skår 1).
  • Rylander R (1996): Airway responsiveness and chest symptoms after inhalation of endotoxin or 1,3, beta-d-glucan. Indoor Build Environ 154:106-111 (Skår 1 (-2))
  • Rylander R et al (1998): Airways inflammation, atopy and (1->3)- beta-D-Glucan exposures in two schools. Am J Respir crit care med 158:1685-7 (Skår 1-2)
  • Rylander R (1999):Indoor-air related effects and airborne (1-3)beta-D-glukan. Env Health Pers 107:501.3 (skår 1-2).
  • Rylander R, Rong-Hwa L (2000): (1->3(-beta-D-glucan - relationship to indoor air-related symptoms, allergy and asthma. Toxicology 152: 47-52. (skår 1)
  • Smith TF et al (1985) : The effect of bacterial lipopolysaccharide on histamine release from human basophils. Clin Immunopath; 14:355- 65 (Skår 1)
  • Snapper C et al (1991): IgE-class switching is critically dependent upon the nature of the B-cell activator, in addition to the presence of Il-4. J Immunol 147:1163-70.
  • Thorne P S (2000): Inhalation toxicology models of endotoxin- and bioaerosol-induced inflammation. Toxicology 152:13-23.
  • Williams P Brock et al (1997): Endotoxin as a factor in adverse reactions to latex gloves. Ann Allergy Asthma and Immunol 79:303- 310 (Skår 1-2)
  • Wan G-H, Li C-S (1999): Indoor endotoxin and glucan in association with airway inflammation and systemic symptoms Arch Environ Health 54: 172-179. (skår 1-2)
  • Williams D L (1997): Overview of (1->3)-beta-D-glucan immunobiology. Mediators infl 6:247-250 (Skår 1).

Utskriftsvennlig versjon





DU ER HER :

ForsideEndotoksin- og Mykotoksin-litteratur

 

AKTUELLE KATEGORIER :
mikroorganismer
sopp og mugg
litteratur